| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.005 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |